Călin Flaviu Ladașiu Ciolacu

Călin Flaviu Ladașiu Ciolacu

Auto-generated profile, based on publicly available information

Călin Flaviu Ladașiu Ciolacu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2018 in Studia Universitatis Babeș-Bolyai Chemia
Verified
Journal Article
Open access
CMCiprian Valentin Mihali
Ciprian Valentin Mihali
CCCălin Flaviu Ladașiu Ciolacu
Călin Flaviu Ladașiu Ciolacu
LFLucian Frențescu
Lucian Frențescu
CPConstantin-Marian Petrescu
Constantin-Marian Petrescu
IMIulia Mândruțiu
Iulia Mândruțiu
GBGheorghe Benga
Gheorghe Benga
Phenylketonuria (PKU) is a genetic disorder which can lead to serious long-term complications in children, including intellectual impairment. The cerebral damage can be largely eliminated if hyperphenilalaninemia (HPA) and PKU is detected by newborn screening and the dietary treatment (started no later than 10 days after birth), brings within 15 days the blood Phe level in the ranges 2 - 6 mg/dL (or equivalently 120 - 360 µmol/L). Consequently, the measurement of plasma Phe level in children with PKU is of utmost importance. We present here in detail two methods for determination of plasma Phe concentrations in children with HPA (detected by newborn screening) or suspected to have PKU based on clinical symptoms. The first method, involving two-dimensional thin-layer chromatography (2D - TLC) on micro scale chromatograms, allows the identification of patients with PKU. However, the quantitation of plasma Phe concentration by the 2D - TLC video-densitometric method is only semiquantitative, because is accompanied by large errors. In contrast, the high performance liquid chromatography determination of the plasma Phe level is fast, very sensitive and higly accurate. Both methods are rather cheap and reliable, suitable for use in countries that cannot afford more expensive procedures for diagnosis and monitoring of PKU.